Durable response for ampullary and duodenal adenocarcinoma with a nab‐paclitaxel plus gemcitabine ± cisplatin combination

Durable response for ampullary and duodenal adenocarcinoma with a nab‐paclitaxel plus gemcitabine ± cisplatin combination

Abstract Background/Aim There is no standard salvage chemotherapy for metastatic periampullary adenocarcinoma and duodenal adenocarcinoma and the prognosis of those who fail oxaliplatin, irinotecan, and 5FU is dismal. We examined nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel) as salvage ther...

Full description

Bibliographic Details
Main Authors: Putao Cen, Curtis J. Wray, Songlin Zhang, Nirav C. Thosani, Brian Cuong Dinh, Anneliese Gonzalez, Virginia Mohlere, John Steven Bynon
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Cancer Medicine
Subjects:
adenocarcinoma
ampullary
cisplatin
CK7
duodenal
gemcitabine
Online Access:https://doi.org/10.1002/cam4.2181

Internet

https://doi.org/10.1002/cam4.2181

Similar Items